Which of the following is true regarding patient selection for targeted therapy?
Show answer and explanation
Correct answer: Only patients whose tumours express the target benefit
The efficacy of targeted therapy depends on the presence of the target; therefore only those patients whose tumours express the target are likely to benefit.
Practice all 20 Immunotherapy and Targeted Therapy questions
Keep practicing
More Immunotherapy and Targeted Therapy questions
- The term “durable response” in cancer immunotherapy means:
- Which of the following is a potential limitation of targeted therapy?
- Which of the following best describes “on-target off-tumour” toxicity in targeted therapy?
- A patient being considered for targeted therapy should have which of the following performed?
- A nurse monitors a patient on immunotherapy for signs of “cytokine release syndrome” (CRS). This adverse effect is most often associated wi…
- In immunotherapy, the term “checkpoint” refers to: